Cite
Kajikawa T, Briones RA, Resuello RRG, et al. Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates. Mol Ther Methods Clin Dev. 2017;6:207-215doi: 10.1016/j.omtm.2017.08.001.
Kajikawa, T., Briones, R. A., Resuello, R. R. G., Tuplano, J. V., Reis, E. S., Hajishengallis, E., Garcia, C. A. G., Yancopoulou, D., Lambris, J. D., & Hajishengallis, G. (2017). Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates. Molecular therapy. Methods & clinical development, 6207-215. https://doi.org/10.1016/j.omtm.2017.08.001
Kajikawa, Tetsuhiro, et al. "Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates." Molecular therapy. Methods & clinical development vol. 6 (2017): 207-215. doi: https://doi.org/10.1016/j.omtm.2017.08.001
Kajikawa T, Briones RA, Resuello RRG, Tuplano JV, Reis ES, Hajishengallis E, Garcia CAG, Yancopoulou D, Lambris JD, Hajishengallis G. Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates. Mol Ther Methods Clin Dev. 2017 Aug 18;6:207-215. doi: 10.1016/j.omtm.2017.08.001. eCollection 2017 Sep 15. PMID: 28879212; PMCID: PMC5577415.
Copy
Download .nbib